php Natural Products from Eucommia ulmoides | BioCrick

Natural Products from Eucommia ulmoides

Natural Products Isolated from Eucommia ulmoides

BioCrick provides high-purity natural products and bioactive compounds isolated and purified from natural sources for scientific research.

  • Natural product compounds selected from diverse chemical and biological sources.
  • Broad structural diversity and coverage of biological activities.
  • Product activity information can be supported by published literature, patents and research reports.
  • Natural products can be selected according to source, target, activity and disease research interests.
  • Compounds should be stored according to the product specifications after receipt.
Natural products isolated from Eucommia ulmoides
Natural products isolated from Eucommia ulmoides

Natural Products from Eucommia ulmoides

31 natural product s associated with Eucommia ulmoides

Natural products and bioactive compounds from Eucommia ulmoides
Catalog No. Product Name CAS Number COA
BCN2563 4-Methylumbelliferone
4-Methylumbelliferone chemical structure
90-33-5 COA
BCN8319 alpha-Linolenic acid
alpha-Linolenic acid chemical structure
463-40-1 COA
BCN6231 Asperuloside
Asperuloside chemical structure
14259-45-1 COA
BCN3088 Asperulosidic acid
Asperulosidic acid chemical structure
25368-11-0 COA
BCN5549 Astragalin
Astragalin chemical structure
480-10-4 COA
BCN5355 Aucubin
Aucubin chemical structure
479-98-1 COA
BCN5771 Avicularin
Avicularin chemical structure
572-30-5 COA
BCN5528 Betulin
Betulin chemical structure
473-98-3 COA
BCN1688 Catechin
Catechin chemical structure
154-23-4 COA
BCN5906 Chlorogenic acid
Chlorogenic acid chemical structure
327-97-9 COA
BCN5503 Corosolic acid
Corosolic acid chemical structure
4547-24-4 COA
BCN6432 D-(+)-Fucose
D-(+)-Fucose chemical structure
3615-37-0 COA
BCN6232 Daphylloside
Daphylloside chemical structure
14260-99-2 COA
BCN5597 Epicatechin
Epicatechin chemical structure
490-46-0 COA
BCN5932 Genipin
Genipin chemical structure
6902-77-8 COA
BCN5104 Geniposide
Geniposide chemical structure
24512-63-8 COA
BCN5171 Geniposidic acid
Geniposidic acid chemical structure
27741-01-1 COA
BCN5569 Isoquercitrin
Isoquercitrin chemical structure
482-35-9 COA
BCN1247 Isorhamnetin-3-O-beta-D-Glucoside
Isorhamnetin-3-O-beta-D-Glucoside chemical structure
5041-82-7 COA
BCN1153 Loganin
Loganin chemical structure
18524-94-2 COA
BCN1376 Pinoresinol 4-O-beta-D-glucopyranoside
Pinoresinol 4-O-beta-D-glucopyranoside chemical structure
69251-96-3 COA
BCN1093 Pinoresinol diglucoside
Pinoresinol diglucoside chemical structure
63902-38-5 COA
BCN6315 Procyanidin B2
Procyanidin B2 chemical structure
29106-49-8 COA
BCN6049 Quercetin
Quercetin chemical structure
117-39-5 COA
BCN2771 Quercetin-3-O-sophoroside
Quercetin-3-O-sophoroside chemical structure
18609-17-1 COA
BCN5665 Quercitrin
Quercitrin chemical structure
522-12-3 COA
BCN1684 Rutin
Rutin chemical structure
153-18-4 COA
BCN1022 Schizandrin B
Schizandrin B chemical structure
61281-37-6 COA
BCN2600 Syringaresinol-di-O-glucoside
Syringaresinol-di-O-glucoside chemical structure
66791-77-3 COA
BCN0310 trans-p-Coumaric acid
trans-p-Coumaric acid chemical structure
501-98-4 COA
BCN4327 Ursolic acid
Ursolic acid chemical structure
77-52-1 COA

References

Antioxidant and xanthine oxidase inhibitory activity of Eucommia ulmoides Oliver leaf extracts.[Pubmed: 30033417]


None


Two pairs of phenylpropanoid enantiomers from the leaves of Eucommia ulmoides.[Pubmed: 29996684]


None


Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.[Pubmed: 29985188]


Aucubin (AUC) is a major bioactive ingredient in Eucommia ulmoides, Plantain asiatica, and Aucuba japonica, and has been shown to exert anti-inflammatory, antioxidative, and neuroprotective effects. We explore the neuroprotective effects of AUC in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonian mice. Mice were administered MPTP (30 mg/kg) daily for 5 days, followed by treatment with AUC for 7 days. Measurement of dopamine levels was performed by high-performance liquid chromatography and tyrosine hydroxylase expression was assessed by western blot. Our results showed that AUC treatment improved mobility in the pole descent test and the traction test, and reduced the loss of dopaminergic neurons in MPTP-induced parkinsonian mice. AUC treatment rescued the decreased dopamine and tyrosine hydroxylase levels in the striatum of parkinsonian mice. Furthermore, AUC treatment reduced both microglia and astrocyte activation in the substantia nigra of parkinsonian mice. These findings suggest that AUC exerts neuroprotective effects, in part by reducing inflammation and preserving dopaminergic neurons. Possible protection mechanisms involved in MPTP-induced parkinsonian mice need to be clarified further.